Local
VETmAb Bio Pursuing Monoclonal Antibodies for Pet Health
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: San Diego Business Journal

-Advertisement- HomeLife Science Biotechenews VETmAb Bio Pursuing Monoclonal Antibodies for Pet Health BIOTECH: Lead Drug Candidate For Canine Equivalent of IBD By Eli Walsh November 19, 2026 Denise Bevers, pictured with her two dogs, co-founded VETmAb after the acquisition of her previous pet medicine company, KindredBio. The company develops monoclonal antibody-based drugs for common illnesses for cats and dogs. Photo courtesy VETmAb SAN DIEGO – VETmAb Biosciences’ medicines are going to the dogs (and cats).Subscribe to keep readingThis article is for San Diego Business Journal subscribers. Subscribe for full access, or log in if you already subscribe.SubscribeSubscriber log inChecking your subscription… Previous article‘Terrifyingly Beautiful’ Encinitas Coastal Home is a Rarity Eli WalshEli is an award-winning reporter primarily covering the tech and life sciences industries. He previously worked as the San Diego City Hall reporter for the regional wire City News Service.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at San Diego Business Journal


